- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07740343
Remimazolam for Postoperative Sleep in Elderly Patients
Remimazolam and Postoperative Sleep in Elderly Patients Undergoing Laparoscopic Colorectal Cancer Resection: A Randomized, Double-Blind, PSG-Based Controlled Trial
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Laparoscopic radical resection of colorectal cancer is the most commonly used surgical approach for colorectal cancer in elderly patients. Although this technique is less invasive than traditional open surgery, more than 60% of elderly patients still experience significant sleep fragmentation and disturbance in the early postoperative period, making effective sleep preservation a key component of enhanced recovery after surgery (ERAS).
Sedative agents play a critical role in modulating perioperative sleep patterns. Remimazolam, a novel ultra-short-acting benzodiazepine, is considered a promising anesthetic for elderly patients due to its favorable pharmacokinetic profile and minimal dependence on hepatic and renal function. However, its impact on objective sleep architecture remains unclear. Propofol, the most widely used sedative in general anesthesia, has been reported to disrupt sleep cycles in the postoperative period, with inconsistent effects on slow-wave sleep and rapid eye movement (REM) sleep.
Polysomnography (PSG) is the gold standard for assessing sleep architecture, including total sleep time, sleep efficiency, sleep stage distribution, and arousals. Previous studies have demonstrated that remimazolam is associated with improvements in subjective sleep outcomes in surgical patients. However, current research on remimazolam's effects on postoperative sleep after laparoscopic colorectal cancer surgery remains limited, particularly lacking high-quality, prospective, randomized controlled studies using objective PSG measurements to verify whether remimazolam can achieve superior sleep outcomes compared with propofol. Therefore, this study adopts a randomized controlled trial design to verify whether remimazolam is superior to propofol in preserving postoperative sleep quality, providing more evidence-based options for anesthetic management in elderly patients undergoing laparoscopic radical resection of colorectal cancer.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Liqin Deng Deng
- Telefoonnummer: 13909511651
- E-mail: dengliqin71@hotmail.com
Studie Contact Back-up
- Naam: Zeqing Gao Gao
- Telefoonnummer: 19279516862
- E-mail: kkkkrystal0214@163.com
Studie Locaties
-
-
Ningxia
-
Yinchuan, Ningxia, China
- Werving
- General Hospital of Ningxia Medical University
-
Contact:
- Zeqing Gao
- Telefoonnummer: 19279516862
- E-mail: kkkkrystal0214@163.com
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Aged between 65 and 80 years.
- Scheduled for elective laparoscopic radical resection of colorectal cancer.
- American Society of Anesthesiologists (ASA) physical status class II-III.
- Able to understand the study protocol and provide written informed consent.
Exclusion Criteria:
- Known allergy to any study medications.
- Preoperative sleep disorder (Pittsburgh Sleep Quality Index [PSQI] score > 10).
- Regular use of sedatives, antipsychotics or hormonal drugs within the past month.
- Preoperative cognitive impairment, screened using the education-adjusted Mini-Mental State Examination (MMSE).
- Preoperative history of neurological or psychiatric disorders, including Alzheimer's disease, Parkinson's disease, depression and anxiety disorders.
- Severe preoperative comorbidities involving the cardiovascular, cerebrovascular, respiratory, hepatic or renal systems, as follows:New York Heart Association (NYHA) functional class IV; current or recent (within 2 months) congestive heart failure; myocardial infarction or coronary stent implantation within the preceding 3 months; Uncontrolled frequent ventricular premature beats (>5 beats per minute), couplets, triplets, paired ventricular arrhythmias, multifocal ventricular premature beats, or R-on-T phenomenon; Second-degree atrioventricular block (Mobitz II type), third-degree atrioventricular block or sick sinus syndrome without pacemaker implantation; Stroke or transient ischemic attack within the preceding 3 months; Severe hypertension (blood pressure ≥ 180/110 mmHg); Severe respiratory tract infection (including common cold), or maximal voluntary ventilation (MMV) < 30% of the predicted value; Severe hepatic dysfunction (Child-Pugh score > 9); Acute or chronic renal failure without renal replacement therapy: Acute kidney injury was defined as an absolute increase in serum creatinine ≥ 0.3 mg/dL (≥26.5 μmol/L) or a relative increase ≥ 50% from baseline, or urine output < 0.5 mL/(kg·h) for more than 6 consecutive hours. Chronic renal failure or uremia was defined as serum creatinine > 451 μmol/L and estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m².
- Severe coagulation disorders.
- Refusal to participate in the trial.
- Anticipated postoperative admission to the intensive care unit (ICU).
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Dubbele
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Remimazolam (Group R)
Remimazolam was used for both anesthesia induction and maintenance
|
In the remimazolam group, anesthesia was induced with remimazolam 0.2 mg/kg, sufentanil 0.3-0.5 μg/kg, and rocuronium 0.6-0.8
mg/kg.
After 3 minutes of preoxygenation, tracheal intubation was performed, and mechanical ventilation was initiated to maintain PETCO₂ at 30-40 mmHg.
Anesthesia was maintained with continuous infusions of remimazolam and remifentanil, guided by anesthetic depth monitoring.
Rocuronium was supplemented intermittently and discontinued 30 minutes before the end of surgery.Polysomnography (PSG) was performed both preoperatively and postoperatively to measure total sleep time and sleep architecture.
Subjective sleep quality was assessed using validated questionnaires during postoperative follow-up.
|
|
Actieve vergelijker: Propofol (Group P)
Propofol was used for both anesthesia induction and maintenance.
|
In the propofol group, anesthesia was induced with propofol 1.0-1.5 mg/kg, sufentanil 0.3-0.5 μg/kg, and rocuronium 0.6-0.8
mg/kg.
Anesthesia was maintained with continuous infusions of propofol and remifentanil.
All other procedural details were identical to those in the remimazolam group.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Total sleep time (TST) on the first postoperative night
Tijdsspanne: On the first postoperative night
|
Polysomnography (PSG) was used to assess total sleep time on the first postoperative night in both groups.
|
On the first postoperative night
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Richards-Campbell Sleep Questionnaire (RCSQ) Score
Tijdsspanne: Postoperative Day 1, Postoperative Day 2, Postoperative Day 3, Postoperative Day 7
|
Subjective sleep quality assessed via the Richards-Campbell Sleep Questionnaire (RCSQ), ranging from 0 to 100 points, with a higher score indicating better sleep quality.
Result interpretation: A total score < 50 indicates poor sleep quality; 50 - 69 points indicate average sleep quality; ≥ 70 points indicate good sleep quality.
|
Postoperative Day 1, Postoperative Day 2, Postoperative Day 3, Postoperative Day 7
|
|
Pittsburgh Sleep Quality Index (PSQI) Score
Tijdsspanne: 1 month postoperatively
|
Subjective sleep quality assessed via the Pittsburgh Sleep Quality Index (PSQI).
Scores range from 0 to 21; higher scores indicate worse sleep quality.
|
1 month postoperatively
|
|
Resting Visual Analogue Scale (VAS) Pain Score
Tijdsspanne: at 1, 2, and 3 days postoperatively
|
Pain at rest was measured in both groups preoperatively and at 1, 2, and 3 days postoperatively using the Visual Analogue Scale (VAS).
Scores range from 0 to 10; higher scores indicate greater pain intensity.
|
at 1, 2, and 3 days postoperatively
|
|
The incidence of postoperative delirium
Tijdsspanne: at 1, 2, and 3 days postoperatively
|
The incidence of postoperative delirium was evaluated in both groups at 1, 2, and 3 days postoperatively using the 3-Minute Diagnostic Confusion Assessment Method (3D-CAM).
|
at 1, 2, and 3 days postoperatively
|
|
Postoperative cognitive function
Tijdsspanne: at 7 days postoperatively and at 1 month postoperatively
|
Cognitive function was assessed preoperatively, at 7 days postoperatively, and at 1 month postoperatively using the Mini-Mental State Examination (MMSE).
Scores range from 0 to 30; higher scores indicate better cognitive function.
|
at 7 days postoperatively and at 1 month postoperatively
|
|
Sleep efficiency assessed by polysomnography (PSG)
Tijdsspanne: Postoperative Night 1
|
Sleep efficiency measured by polysomnography (PSG).
It is defined as the percentage of sleep time relative to total time spent in bed.
|
Postoperative Night 1
|
|
Number of awakenings after sleep onset assessed by polysomnography (PSG)
Tijdsspanne: Postoperative Night 1
|
Number of awakenings after sleep onset measured by polysomnography (PSG).
|
Postoperative Night 1
|
|
Total wake time assessed by polysomnography (PSG)
Tijdsspanne: Postoperative Night 1
|
Total duration of awakenings during sleep measured by polysomnography (PSG).
|
Postoperative Night 1
|
|
Proportion of each sleep stage assessed by polysomnography (PSG)
Tijdsspanne: Postoperative Night 1
|
Proportion of each sleep stage measured by polysomnography (PSG), including N1,N2,N3 and REM.
|
Postoperative Night 1
|
|
Serum levels of cortisol
Tijdsspanne: on the morning of postoperative day 1
|
Serum levels of cortisol were measured preoperatively and on the morning of postoperative day 1 and compared between the two groups.
|
on the morning of postoperative day 1
|
|
Movement Visual Analogue Scale (VAS) Pain Score
Tijdsspanne: Postoperative Day 1, Postoperative Day 2, Postoperative Day 3
|
Postoperative pain during movement assessed via the Visual Analogue Scale (VAS).
Scores range from 0 to 10; higher scores indicate greater pain intensity.
|
Postoperative Day 1, Postoperative Day 2, Postoperative Day 3
|
|
Serum C-reactive protein (CRP) level
Tijdsspanne: Morning of postoperative day 1
|
Serum concentration of C-reactive protein (CRP).
|
Morning of postoperative day 1
|
|
Serum interleukin-6 (IL-6) level
Tijdsspanne: Morning of postoperative day 1
|
Serum concentration of interleukin-6 (IL-6).
|
Morning of postoperative day 1
|
Medewerkers en onderzoekers
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- RMZ on postoperative sleep
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .